Antiangiogenic therapy in lung cancer: focus on vascular endothelial growth factor pathway.
Affiliation
Department of Medical Oncology, Mater Misericordiae University Hospital, Eccles St, Dublin 7, Ireland. greg.korpanty@gmail.comIssue Date
2010-01MeSH
Angiogenesis InhibitorsAntibodies, Monoclonal
Carcinoma, Non-Small-Cell Lung
Clinical Trials as Topic
Humans
Lung Neoplasms
Neovascularization, Pathologic
Piperidines
Quinazolines
Receptor, Epidermal Growth Factor
Receptors, Vascular Endothelial Growth Factor
Vascular Endothelial Growth Factor A
Metadata
Show full item recordCitation
Antiangiogenic therapy in lung cancer: focus on vascular endothelial growth factor pathway. 2010, 235 (1):3-9 Exp. Biol. Med. (Maywood)Journal
Experimental biology and medicine (Maywood, N.J.)DOI
10.1258/ebm.2009.009191PubMed ID
20404013Abstract
Lung cancer (LC) is a leading cause of death worldwide. Recent advances in chemotherapeutic agents have not yielded any significant improvement in the prognosis of patients with LC. The five-year survival rate for all combined disease stages remains about 15%. For this reason, new therapies such as those that inhibit tumor angiogenesis or block activity of growth factor receptors are of special interest in this group of patients. In this review we will summarize the most recent clinical data on biologic therapies that inhibit tumor angiogenesis in LC, focusing on those that are most clinically relevant.Item Type
PreprintLanguage
enISSN
1535-3699ae974a485f413a2113503eed53cd6c53
10.1258/ebm.2009.009191
Scopus Count
Collections
Related articles
- Emerging data with antiangiogenic therapies in early and advanced non-small-cell lung cancer.
- Authors: Horn L, Sandler AB
- Issue date: 2009 Mar
- Drug insight: VEGF as a therapeutic target for breast cancer.
- Authors: Schneider BP, Sledge GW Jr
- Issue date: 2007 Mar
- Antiangiogenic drugs in non-small cell lung cancer treatment.
- Authors: Cascone T, Troiani T, Morelli MP, Gridelli C, Ciardiello F
- Issue date: 2006 Mar
- Combined inhibition of vascular endothelial growth factor and epidermal growth factor signaling in non-small-cell lung cancer therapy.
- Authors: Pakkala S, Ramalingam SS
- Issue date: 2009 Mar
- [Targeted therapies. New hopes, new challenges].
- Authors: Barlési F
- Issue date: 2008 Jun